4//SEC Filing
Kenney Richard T 4
Accession 0001493152-22-036312
CIK 0001106838other
Filed
Dec 21, 7:00 PM ET
Accepted
Dec 22, 4:30 PM ET
Size
5.1 KB
Accession
0001493152-22-036312
Insider Transaction Report
Form 4
Kenney Richard T
Chief Medical Officer
Transactions
- Award
Common Stock
2022-12-14+14,627→ 64,627 total
Footnotes (2)
- [F1]On December 14, 2022, the Reporting Person was granted 14,627 restricted stock units, which will be settled in shares of common stock, par value $0.0001. The restricted stock units vest as to 100% of the restricted stock units on January 1, 2024.
- [F2]Includes unvested RSUs.
Documents
Issuer
Sonnet BioTherapeutics Holdings, Inc.
CIK 0001106838
Entity typeother
Related Parties
1- filerCIK 0001606653
Filing Metadata
- Form type
- 4
- Filed
- Dec 21, 7:00 PM ET
- Accepted
- Dec 22, 4:30 PM ET
- Size
- 5.1 KB